Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient
US9089530B2 · kind B2 · utility
1Cited by
1References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 18, 2011 |
| Grant date | Jul 28, 2015 |
| Priority date | — |
| Expiry date | Sep 2, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is an antimalarial drug which is useful for prevention and treatment of infectious diseases caused by malaria parasites. A preventive and/or therapeutic agent for malaria, which contains, as an active ingredient, 5-aminolevulinic acid (ALA), a derivative thereof, or a pharmacologically acceptable salt thereof, is used.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.